1. Home
  2. CLRB vs MLGO Comparison

CLRB vs MLGO Comparison

Compare CLRB & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • MLGO
  • Stock Information
  • Founded
  • CLRB 2002
  • MLGO 2018
  • Country
  • CLRB United States
  • MLGO China
  • Employees
  • CLRB N/A
  • MLGO N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • MLGO EDP Services
  • Sector
  • CLRB Health Care
  • MLGO Technology
  • Exchange
  • CLRB Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • CLRB 17.6M
  • MLGO 15.6M
  • IPO Year
  • CLRB N/A
  • MLGO N/A
  • Fundamental
  • Price
  • CLRB $4.92
  • MLGO $14.66
  • Analyst Decision
  • CLRB Hold
  • MLGO
  • Analyst Count
  • CLRB 2
  • MLGO 0
  • Target Price
  • CLRB N/A
  • MLGO N/A
  • AVG Volume (30 Days)
  • CLRB 173.9K
  • MLGO 33.0M
  • Earning Date
  • CLRB 08-12-2025
  • MLGO 04-28-2025
  • Dividend Yield
  • CLRB N/A
  • MLGO N/A
  • EPS Growth
  • CLRB N/A
  • MLGO N/A
  • EPS
  • CLRB N/A
  • MLGO 16.40
  • Revenue
  • CLRB N/A
  • MLGO $74,185,505.00
  • Revenue This Year
  • CLRB N/A
  • MLGO N/A
  • Revenue Next Year
  • CLRB N/A
  • MLGO N/A
  • P/E Ratio
  • CLRB N/A
  • MLGO $1.08
  • Revenue Growth
  • CLRB N/A
  • MLGO N/A
  • 52 Week Low
  • CLRB $4.36
  • MLGO $0.50
  • 52 Week High
  • CLRB $94.50
  • MLGO $59.40
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 36.75
  • MLGO 32.95
  • Support Level
  • CLRB $4.74
  • MLGO $18.00
  • Resistance Level
  • CLRB $5.33
  • MLGO $26.40
  • Average True Range (ATR)
  • CLRB 0.40
  • MLGO 3.16
  • MACD
  • CLRB -0.00
  • MLGO 2.76
  • Stochastic Oscillator
  • CLRB 18.43
  • MLGO 7.56

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: